Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $37.2500 (7.81%) ($34.7000 - $37.4500) on Fri. Jan. 26, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.56% (three month average) | RSI | 89 | Latest Price | $37.2500(7.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 4.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 30.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(51%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -2.78% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-11%) UNG(-4%) TIP(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.78% (StdDev 5.56%) | Hourly BBV | 0 () | Intraday Trend | 4.2% | | | |
|
5 Day Moving Average | $34.77(7.13%) | 10 Day Moving Average | $31.69(17.54%) | 20 Day Moving Average | $25.57(45.68%) | To recent high | 0% | To recent low | 182.2% | Market Cap | $2.768b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |